English
中文

Press Release

Event Review back >

3rd Healthcare Asia Pacific Summit 2018

June 6-8, 2018 · Four Points by Sheraton Singapore, Riverview

Duxes held the 3rd Healthcare Asia Pacific Summit 2018 on June 6-8, 2018 in Singapore. The two-and-a-half day event gathered leading voices in the healthcare field, discussing the market environment in jurisdictions across the region, access to new markets, regulatory compliance, clinical trial management, and a range of other important issues.

The summit opened with a pre-event special that addressed clinical trial management, and included presentations detailing quality assurance, strategies, and a value-centric approach, as well as a discussion on regulatory and market conditions for clinical trials in the Asia Pacific region. The following two days featured testimony from leading healthcare professionals and policymakers, on the policy environment for medical devices in Japan, China, Malaysia, and Australia, with information on key reforms, the WHO’s efforts to harmonize global regulations, cutting-edge data management, and evidence-based analysis. Panels delved into comparative analysis of regulatory regimes across Asia, market access for new products, and the latest in medical device supply chains and distribution.

Duxes is proud to report that the 3rd Healthcare Asia Pacific Summit 2018 was lauded by delegates for its timely content and interactive format. The event provided a platform for open exchange, and the sharing of the latest regulatory developments in the fast-developing Asian medical device and pharmaceutical markets. Special thanks are owed to the expert speakers and panelists who contributed essential knowledge, as well as endorsers: European Medical Association and the Singapore Manufacturing Federation, and collaborating organizations that helped make the summit possible.

Contact Information:
Ms. Cindy Cui
Tel.: +86 21 5258 8005 Ext. 8253
E-mail: cindy.cui@duxes.cn